Cost-Effectiveness Of Rivaroxaban Versus Warfarin For Treatment Of Nonvalvular Atrial Fibrillation In Patients With Worsening Renal Function

May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.371
https://www.valueinhealthjournal.com/article/S1098-3015(18)30671-5/fulltext
Section Title :
Section Order : 1229
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30671-5&doi=10.1016/j.jval.2018.04.371
HEOR Topics :
Tags :
Regions :